ChinaBio^® Partnering Forum 2012 Press Releases

16 January 2012 Biotech funding 2012: Innovation is not enough Venture capital is the most expensive form of capital, so companies are advised to be creative in sourcing other types of funding. With the current capital headwinds, creative alternatives may be the only options companies have. more ►

13 January 2012 Lights are flashing green for biotech investment in China While the rest of the world struggles, China is setting new records in venture capital investment, IPO and M&A activity, and partnering deals. more ►

13 January 2012 The exciting state of regenerative medicine Regenerative medicine has the power to transform healthcare, incorporating a wide variety of therapies. When incorporated into clinical practice, regenerative therapies may save USD 250 billion per year in the US alone. more ►

13 January 2012 Biotech investors declare it’s never too early to plan an exit It’s never too early to plan an exit strategy. Panelists at the Biotech Showcase™ 2012 luncheon plenary session Monday all agreed that, although that strategy may include an IPO, exit planning should include other strategies as well. more ►

4 January 2012 Anton Gueth: Troublesome financing environment to hit early stage companies hard in 2012 The excitement of the industry insiders is unfortunately not matched by those funding and regulating it. The challenges facing the industry are increasing every day. more ►